KeyBank National Association’s Takeda Pharmaceutical TAK Stock Holding History

KeyBank National Association’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$447K	Sell	27,884 -11,331	-29%	-$187K	﹤0.01%	976
2026 Q1	$726K	Buy	39,215 +26,369	+205%	+$463K	﹤0.01%	681
2025 Q4	$200K	Buy	+12,846	New	+$184K	﹤0.01%	1167
2025 Q3	–	Sell	-13,376	Closed	-$207K	–	1221
2025 Q2	$207K	Buy	13,376 +1,603	+14%	+$23.7K	﹤0.01%	1115
2025 Q1	$175K	Buy	+11,773	New	+$165K	﹤0.01%	1120
2024 Q1	–	Sell	-10,866	Closed	-$155K	–	1120
2023 Q4	$155K	Buy	+10,866	New	+$154K	﹤0.01%	1051

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

KeyBank National Association's TAK Position: Q2 2026 in Review

KeyBank National Association reduced its Takeda Pharmaceutical (TAK) stake by 29% in Q2 2026, selling an estimated $187K and leaving 27,884 shares worth $447K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

KeyBank National Association first reported a position in TAK in Q4 2023 and has held it in 6 quarters since. The position peaked at $726K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

KeyBank National Association held 27,884 shares of Takeda Pharmaceutical worth $447K as of Q2 2026.
KeyBank National Association sold 11,331 Takeda Pharmaceutical shares in Q2 2026, an estimated $187K.
Takeda Pharmaceutical made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #976 holding.
KeyBank National Association first reported a position in Takeda Pharmaceutical in Q4 2023 and has held it in 6 quarters since.
KeyBank National Association's Takeda Pharmaceutical position peaked at $726K in Q1 2026.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.